Concepedia

Chengfei Liu

CL

Statistics

Publications

48

Citations

3.1K

H-Index

29

Active since

2011

Affiliations

University of California, Davis(Current)

VA Northern California Health Care System

UC Davis Comprehensive Cancer Center

Second Affiliated Hospital of Xi'an Jiaotong University

University of California Davis Medical Center

Chengfei Liu is an author at University of California, Davis specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

2011–2024

48

Publications

48

Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Clinical Cancer Research · 2014 · 353 citations · Full text

, , +16

Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Cancer Research · 2015 · 242 citations · Full text

, , +17

NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu et al. · Molecular Cancer Therapeutics · 2013 · 186 citations · Full text

, , +17

Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer

Yezi Zhu, Chengfei Liu, Nagalakshmi Nadiminty et al. · Molecular Cancer Therapeutics · 2013 · 125 citations · Full text

, , +16

EXPRESSION OF CONCERN: Functional p53 determines docetaxel sensitivity in prostate cancer cells

Chengfei Liu, Yezi Zhu, Wei Lou et al. · The Prostate · 2012 · 122 citations · Full text

, , +17

1–5 of 48